Infections are a real problem in immunosuppressed patients, but many are predictable and preventable. Check out our article and podcast on some strategies to protect patients from serious infections! @aadith_ashok
https://t.co/N3wynHfo0n
📘February issue now available➡️https://t.co/2cQ7Mny3xv This issue explores psychotropic medicines in people with cognitive disability or impairment, ADHD management in adults, and more! #healthcare#freejournal#independentpeerreview
The NHMRC yesterday announced final allocations for the year. The 2025 success rate for Ideas grants was 10%, Investigator grants 13%, and Clinical Trials 9%.
Australia's total spend on healthcare and technology innovation in medicine and biotech from the Medical Research Endowment Account and Medical Research Future Fund this year will equate to the cost of 0.004 submarines.
We're spending more on a single submarine than we'll spend on medical research in 30 years.
Medical research matters. A clever country invests in the things that matter.
check out our review of donor-derived infections in heart & lung transplant recipients! was a pleasure working with @MichaelGIsonMD on this! https://t.co/xFmxKxbSKj
pleased to share our latest study showing that absolute lymphocyte count and donor serostatus can predict CMV within R+ lung transplant recipients! https://t.co/4gRmQCsaCH
We reviewed the experience of our lung transplant recipients who acquired COVID , and found that with high vaccine/treatment uptake, outcomes are overall pretty good! @TxID@TheJHLT@ISHLT
https://t.co/UUF9ph5QRk
Pleased to share our report on the first in-human use of a new inhaled form of voriconazole, which has great potential for prophylaxis/treatment of pulmonary fungal infections, minimizing systemic toxicity https://t.co/coDzyhl3L0 #TxID@TheTxIDjournal@TFFPharma
This @TheTxIDjournal review of infection after CAR-T is unique in having a timeline of infection!
Also tables of anti-infective prophylaxis!
Added by Ashrit Multani @UCLA_ID to the "HEME-ONC AND CELLULAR THERAPIES"▶️"CAR-T"📂
https://t.co/pCbZji1jdb
“They paged me what?”: A transplant infectious disease guide to donor calls
Proud of this paper, & some great co-authors who conceived it. Understanding and balancing donor risk is not something we frankly teach well. We try to tease it out here❤️
https://t.co/ftECVyumu9
🆕️⚡️Impact of posaconazole prophylaxis and antifungal treatment on BAL GM performance in hematology malignancy patients with febrile neutropenia: a real life experience ⚡️🆕️ #IDXposts#MedEd
https://t.co/keDUZ4Qzbq
A study providing important data on the importance of posaconazole monitoring in venetoclax-treated MDS/AML populations. @GemmaKReynolds @KarenUrbancic @chunyewfong @TrubianoJason@id_austin
https://t.co/NPinV8LLib
🚨📚CMV in Solid Organ Transplantation: @KottonNelson and I go through the major updates since publication of the last international consensus guidelines in @TransplantJrnl 🫁🫀🫘
https://t.co/CsZoKrLdtV
The risk AmpC derepression is not equal among Enterobacterales!
🆕️⚡️🌟An antimicrobial stewardship intervention was associated with ⬆️ ceftriaxone prescribing & similar patient outcomes in patients with severe infections with low & no-risk AmpC E #MedEd
https://t.co/wHX3733IrR
🆕️⚡️🌟 @TheLancetInfDis@Sara_Alosaimy@IDpharmresearch@SakoulasGeorge
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis,proximal renal tubule mitochondrial metabolism & β-lactam chemistry
ACORN isn't included
https://t.co/5KFErro8QM